| abstract |
Described herein are compounds that modulate the activity of 5-lipoxygenase-activating protein (FLAP) and pharmaceutical compositions containing the compounds. Also, methods of using such FLAP modulators alone and other compounds for treating respiratory symptoms or diseases, cardiovascular symptoms or diseases, and other leukotriene-dependent or leukotriene-mediated symptoms or diseases and other compounds A method of use in combination is also described. |